Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma

M. Vestergaard, A. Sverrild, V. Backer, C. Porsbjerg (Copenhagen, Denmark)

Source: International Congress 2014 – Systemic and airway biomarkers
Session: Systemic and airway biomarkers
Session type: Poster Discussion
Number: 2046
Disease area: Airway diseases

Congress or journal article abstract

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Vestergaard, A. Sverrild, V. Backer, C. Porsbjerg (Copenhagen, Denmark). Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma. Eur Respir J 2014; 44: Suppl. 58, 2046

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013


The difference of FENO levels according to gender in healty subjects never smoked
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Informativity of biometric and functional parameters for asthma control verification in children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016

Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Normal values of exhaled nitric oxide at 50 mL/s – A revisit
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

The effects of oral care on FeNO measurement in asthmatic patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma
Source: Annual Congress 2013 –Asthma
Year: 2013


Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015


Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015

Prevalence and relationship of hypomagnesiemia with children bronchial asthma control
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016

The diagnostic accuracy of allergen-specific IgE and its relation to exhaled nitric oxide in children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016